In the fiscal year ending December 2024, VIS will promote mRNA-targeted small molecule drug discovery business and the creation of its own pipeline.

Veritas In Silico <130A> announced its fiscal results for the year ending December 2024 on the 13th. Business revenue decreased by 46.0% compared to the previous year to 0.194 billion yen, with an operating loss of 0.212 billion yen (compared to a profit of 0.037 billion yen in the previous term), an ordinary loss of 0.233 billion yen (compared to a profit of 0.035 billion yen in the previous term), and a net loss of 0.236 billion yen (compared to a profit of 0.033 billion yen in the previous term). In the company's mRNA-targeted small molecule drug discovery business, the drug discovery platform ibVIS(R) is being utilized, and TORAY INDS INC <3402>.

Fisco JapanFeb 14 01:52 ET

Rating Information (Target Price Change - Part 2) = Nissui, F&LC, ETC.

◎ Mizuho Securities (three-tier: Buy > Hold > underperform) Nissui <1332.T> -- "Buy" → "Buy", 1270 yen → 1300 yen Ariake <2815.T> -- "Buy" → "Buy", 7500 yen → 7700 yen F&LC <3563.T> -- "Buy" → "Buy", 4000 yen → 4800 yen Goldwin <8111.T> -- "Buy" → "Buy", 15000 yen → 13000 yen Sumitomo Warehouse <9303.T> -- "Hold" → "Hold", 2600 yen →

Kabushiki ShimbunFeb 12 19:53 ET

List of conversion stocks (part 2) [List of stocks converting with Parabolic Signals]

○ List of stocks undergoing a Sell conversion in the market Code Stock Name Closing Price SAR Main Board <1375> Yukiguni Maitake 1203 <1802> Obayashi Corporation 1236 <1835> Tokyu Construction 20822204 <1890> Toyo Construction 31803265 <1952> Shin Nippon Air Conditioning 16822027 <2001> Nippn 21422204 <2222> Kotobuki Spirits 24592591 <2730> Edion 1

Fisco JapanFeb 12 17:49 ET

The New York market on the 6th was mixed [New York market - Close].

[NYDow・NASDAQ・CME (Table)] NYDOW; 44747.63; −125.65 NASDAQ; 19791.99; +99.66 CME225; 38970; -120 (Compared to the Osaka Exchange) [NY Market Data] The NY market on the 6th was mixed. The Dow Jones Industrial Average closed down by $125.65 at $44,747.63, while the NASDAQ finished up by 99.66 points at $19,791.99. Expectations of additional rate cuts and favorable earnings reports from some major companies contributed to a solid opening.

Fisco JapanFeb 6 18:14 ET

The US Stocks market is mixed, wary of the Employment Statistics (6th).

The Chicago Nikkei Average Futures (CME) on the 6th: MAR24O 38985 (in USD) H 39235 L 38865 C 39010, compared to the Osaka Exchange -80 (evening comparison +40) Vol 5742 MAR24O 38930 (in JPY) H 39190 L 38830 C 38970, compared to the Osaka Exchange -120 (evening comparison +0) Vol 23180. The overview of American Depositary Receipts (ADR) on the 6th shows that in the ADR market, compared to the Tokyo Stock Exchange (1 USD is equivalent to 151.41 JPY), Japan.

Fisco JapanFeb 6 18:13 ET

Regarding sponsorship for "Rare Disease Day 2025 (World Rare and Undiagnosed Diseases Day)".

Regarding the sponsorship for "Rare Disease Day 2025 (World Rare and Intractable Diseases Day)" from February 5, 2025 to the end of February, on "World Rare and Intractable Diseases Day", promoting understanding of rare and intractable diseases - sponsoring officially recognized events by the RDD Japan Secretariat - conducting a sponsor session at the RDD Tokyo event on February 28 (Friday).

Takeda PharmaceuticalFeb 4 10:00 ET